Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Propylene Glycol-Free Melphalan vs Alkeran in MM Patients
NCT00925782Phase 2Completed
- Sponsor
- Acrotech Biopharma Inc
- Start
- Jan 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of EVOMELA in multiple myeloma (MM), sponsored by Acrotech Biopharma Inc. Started Jan 2010; status: completed.
02
Drugs
EVOMELA
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00925782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00925782.